Abstract
KIF1A-associated neurological diseases (KANDs) are a group of inherited conditions caused by changes in the microtubule (MT) motor protein KIF1A as a result of KIF1A gene mutations. Anterograde transport of membrane organelles is facilitated by the kinesin family protein encoded by the MT-based motor gene KIF1A. Variations in the KIF1A gene, which primarily affect the motor domain, disrupt its ability to transport synaptic vesicles containing synaptophysin and synaptotagmin leading to various neurological pathologies such as hereditary sensory neuropathy, autosomal dominant and recessive forms of spastic paraplegia, and different neurological conditions. These mutations are frequently misdiagnosed because they result from spontaneous, non-inherited genomic alterations. Whole-exome sequencing (WES), a cutting-edge method, assists neurologists in diagnosing the illness and in planning and choosing the best course of action. These conditions are simple to be identified in pediatric and have a life expectancy of 5–7 years. There is presently no permanent treatment for these illnesses, and researchers have not yet discovered a medicine to treat them. Scientists have more hope in gene therapy since it can be used to cure diseases brought on by mutations. In this review article, we discussed some of the experimental gene therapy methods, including gene replacement, gene knockdown, symptomatic gene therapy, and cell suicide gene therapy. It also covered its clinical symptoms, pathogenesis, current diagnostics, therapy, and research advances currently occurring in the field of KAND-related disorders. This review also explained the impact that gene therapy can be designed in this direction and afford the remarkable benefits to the patients and society.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference110 articles.
1. Multigeneration family with dominant SPG30 hereditary spastic paraplegia;Roda;Ann. Clin. Transl. Neurol.,2017
2. KIF1A -related disorders in children: A wide spectrum of central and peripheral nervous system involvement;Nemani;J. Peripher. Nerv. Syst.,2020
3. Genotype and defects in microtubule-based motility correlate with clinical severity in KIF1A-associated neurological disorder;Boyle;Hum. Genet. Genom. Adv.,2021
4. Cerebellar Atrophy in Congenital Fibrosis of the Extraocular Muscles Type 1;Comanducci;Cerebellum,2012
5. Baptista, F., Pinto, M.J., Elvas, F., Almeida, R., and Ambrósio, A.F. (2013). Diabetes Alters KIF1A and KIF5B Motor Proteins in the Hippocampus. PLoS ONE, 8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献